H1N1 Immunity: Inactivated vs. Live Attenuated Flu Vaccines Compared

Active immunity to H1N1 is achieved through vaccination. Two main platforms exist for influenza vaccines, each with distinct characteristics.

Inactivated Influenza Vaccine (IIV)

  • Types: Standard-dose (SD-IIV4), High-dose (HD-IIV4, 60µg HA), Adjuvanted (aIIV4, MF59), Recombinant (RIV4, egg-free), Cell-based (ccIIV4).
  • Route: Intramuscular (deltoid or anterolateral thigh).
  • Doses: 1 dose annually (≥9 years); 2 doses (4 weeks apart) if first vaccination <9 years.
  • Mechanism: Killed virus → HA antigens presented → humoral (anti-HA IgG) and cellular immunity.
  • Side Effects: Injection site pain/swelling (10–60%), low-grade fever, myalgia (1–10%). Cannot cause flu.
  • Contraindications: Severe allergic reaction to prior dose or component (except egg).
  • Precautions: Moderate/severe acute illness; Guillain-Barré syndrome within 6 weeks of prior flu vaccine.

Live Attenuated Influenza Vaccine (LAIV)

  • Formulation: Cold-adapted, temperature-sensitive, replication-deficient virus. Replicates in nasopharynx (33°C) not lower airways (37°C).
  • Route: Intranasal spray (0.1 mL per nostril).
  • Dose: Single dose annually (≥2 years); 2 doses if first vaccination <9 years.
  • Mechanism: Mucosal IgA + systemic IgG + T-cell immunity; may provide broader heterologous protection.
  • Side Effects: Runny nose, nasal congestion, low-grade fever, sore throat. Can shed vaccine virus (rare transmission).
  • Contraindications: Age <2 or >49; pregnancy; immunocompromise; close contact with severely immunocompromised; asthma/wheezing age 2–4; aspirin/salicylate therapy (Reye's risk); severe egg allergy (historical); recent antivirals.

Comparative Effectiveness

  • IIV: Consistent effectiveness across ages; preferred for high-risk, pregnant, immunocompromised.
  • LAIV: Variable effectiveness by season/strain; historically lower against H1N1pdm09 (2013–2016) → temporarily not recommended (2016–2018); reformulated, now recommended again.
  • Children: Some data suggest LAIV superior for young children; ACIP expresses no preference.

Choosing the Right Vaccine

Decision based on age, health status, pregnancy, preferences, availability. Discuss with healthcare provider. Both are effective tools; any vaccination is better than none.

Huna Hypnotherapy - Related Articles